Figure 1From: Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosisSerum levels (mean, +/- SEM) of TNF-α (A), soluble IL-2R (B), and IL-6 (C) immediately before the first, second and third trAb application, and corresponding serum levels on day one and two dafter trAb therapy. Serum levels were measured by ELISA (Biosource, Fleurs, Belgium). * p < 0.05.Back to article page